Galmed Pharmaceuticals: 2Q Earnings Snapshot
TEL AVIV, Israel (AP) _ Galmed Pharmaceuticals Ltd. (GLMD) on Monday reported a loss of $4.2 million in its second quarter.
The Tel Aviv, Israel-based company said it had a loss of 20 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.
Galmed Pharmaceuticals shares have fallen 17% since the beginning of the year. The stock has fallen 58% in the last 12 months.